🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVsc9b !
@drtimos.bsky.social
@drtimos.bsky.social🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVsc9b !
@robertlufkinmd.bsky.socialMy take: metabolic progress and tolerability belong in the same conversation.
Full breakdown coming on the Health Longevity Secrets podcast www.youtube.com/@RobertLufkinMD
#MetabolicHealth #HealthLongevitySecrets #Diabetes #ClinicalTrials (4/4)
@newsramp.comLantern Pharma (NASDAQ: LTRN) secures Taiwan approvals to advance Part 2 of its Phase 2 HARMONIC trial for LP-300, targeting EGFR L858R mutation patients. U.S. sites also begin identifying eligible patients as the trial expands. #Oncology #ClinicalTrials
@newsramp.comNewron Pharmaceuticals receives FDA written communication on clinical hold for evenamide Phase 3 trial. Enrollment outside the U.S. continues; topline data expected Q1 2027. Mortality rate adjusted for treatment duration was lower for evenamide than placebo. #Schizophrenia #ClinicalTrials
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVs6b9
@ASCO
#SocialListening #LucidQuest
@gregoryai.bsky.socialNew clinical trial
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
@gregoryai.bsky.socialNew clinical trial
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
@gmj-georgia.bsky.socialThe obesity drug industry is shifting gears. Instead of chasing maximum weight loss, developers now prioritize tolerability and patient persistence—recog… #Clinicaltrials #Drugdevelopment #Obesity #Pharmacotherapy #Tolerability #Clinicaltrials #Drugdevelopment #Obesity #Pharmacotherapy #Tolerab…
@jmirlatestresearch.bsky.socialJMIR Mental Health: Incorporating Objective Behavioral and Biological Measures in a Large-Scale Decentralized Mobile #Health Trial for #depression: Randomized Controlled Trial #MentalHealth #DigitalHealth #Depression #ClinicalTrials #Wellbeing
@jama.com🔖 This October's Trial Theme of the Month focuses on extension studies in #ClinicalTrials, where long-term findings depend on how comparison groups are defined and how attrition and selection bias are handled.
🔗 Read the latest editorial: ja.ma/4zqdoBD
@jama.com💬 Editorial: In #ClinicalTrials, extension studies that rely on external controls, simulated comparators, or crossover designs can add useful long-term outcome data, but each approach introduces trade-offs in internal validity and interpretability.
@liposarcomasupport.bsky.socialThe ATLAS study is investigating actinium-based targeted therapy for patients with late-stage aggressive sarcomas. To learn more about eligibility and study details, visit: clinicaltrials.gov/study/NCT071...
#sarcoma #clinicaltrials #ATLAS #RTX2358
@gregoryai.bsky.socialNew clinical trial
A Single-center, Single-arm, Prospective, Open-label, Pilot Clinical Trial to Evaluate the Safety and Efficacy of the Focused Ultrasound Stimulator System (NMS-01) for Transient Blood-Brain Barrier (BBB) Opening in Patients...
@gregoryai.bsky.socialNew clinical trial
Assessing the Validity and Reliability of the Language Memory Test for Use in a Belgian Population of People With Multiple Sclerosis
@newsramp.comTransCode Therapeutics (NASDAQ: RNAZ) reports updated Phase 1a data for TTX-MC138: 71.4% of patients achieved stable disease, zero dose-limiting toxicities across 98 doses, and 40% showed longer progression-free intervals than prior therapy. #Oncology #ClinicalTrials
@newsramp.comQuantum BioPharma (QNTM) signs a Study Start-Up Agreement with Thermo Fisher Scientific to launch a Phase 2 trial of Lucid-MS, its first-in-class neuroprotective treatment for progressive multiple sclerosis, following FDA clearance. #MultipleSclerosis #ClinicalTrials
@newsramp.comIncannex Healthcare ($IXHL) moves IHL-42X into active clinical execution. The DReAMzz study enrolls ~120 patients across 14 U.S. sites, targeting mid-2027 completion, with $68.4M cash on hand supporting at least 12 months of operations. #Biotech #ClinicalTrials
@coloncanada.bsky.socialJoin patient leaders for a panel on faster access to innovation, AI in clinical trials, and how patients are shaping the future of research.
📅 Oct. 20 | 10:15–11:15 a.m.
📍 Holiday Inn & Suites Montreal Centre-Ville Ouest
🔗 tinyurl.com/PACT-2026
@themednet.bsky.socialVisit us at the Mednet TrialMatch Demo Booth (West Tower, Ballroom Level) for a live demo, or try it now.
Start a search: tinyurl.com/tyutzfkz
@byteandpieces.bsky.social📣 New Podcast! "The Accidental Anti-Aging Drug: How AI Is Changing Everything" on @Spreaker #ai #antiaging #biohacking #biotech #biotechnology #clinicaltrials #drugdiscovery #futureofmedicine #futuretech #genetics #healthspan #healthtech #innovation #insilicomedicine #longevity #medicine